AnaptysBio Inc (NASDAQ:ANAB) Has Reached A Distance Of 48.48% From Its Low, So Is It Poised For More Gains?

In last trading session, AnaptysBio Inc (NASDAQ:ANAB) saw 0.68 million shares changing hands with its beta currently measuring -0.26. Company’s recent per share price level of $23.70 trading at $2.56 or 12.11% at ring of the bell on the day assigns it a market valuation of $696.31M. That closing price of ANAB’s stock is at a discount of -74.3% from its 52-week high price of $41.31 and is indicating a premium of 48.48% from its 52-week low price of $12.21.

For AnaptysBio Inc (ANAB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

AnaptysBio Inc (NASDAQ:ANAB) trade information

AnaptysBio Inc’s shares saw a change of 79.00% in year-to-date performance and have moved 6.61% in past 5-day. AnaptysBio Inc (NASDAQ:ANAB) showed a performance of 20.43% in past 30-days.

Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 5.2% to its current value. Analysts have been projecting 19 as a low price target for the stock while placing it at a high target of 54. It follows that stock’s current price would jump 19.83% in reaching the projected high whereas dropping to the targeted low would mean a gain of 19.83% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -7.30% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -2.88% while estimates for its earnings growth in next 5 years are of -2.22%.

AnaptysBio Inc (NASDAQ:ANAB)’s Major holders

ECOR1 CAPITAL, LLC is the top institutional holder at ANAB for having 7.52 million shares of worth $188.48 million. And as of 2024-06-30, it was holding 27.4931 of the company’s outstanding shares.

The second largest institutional holder is FMR LLC, which was holding about 2.87 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.4936 of outstanding shares, having a total worth of $71.94 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Securities Fund-Fidelity Small Cap Growth Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 668.95 shares of worth $15.85 million or 2.28% of the total outstanding shares. The later fund manager was in possession of 625.15 shares on Feb 28, 2025 , making its stake of worth around $14.82 million in the company or a holder of 2.13% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.